210 related articles for article (PubMed ID: 27119139)
21. A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.
Bot A; Ahn M; Bosch M; Brockstedt D; Butterfield LH; Cornforth A; Harrop R; Kast WM; Koya R; Marincola F; Margolin K; McCoy C; Pawelec G; Rothman J; Ramirez-Montagut T; Schlom J; Srivastava P; Wallis S; Walter S; Wang E; Waslif J
J Transl Med; 2012 Nov; 10():218. PubMed ID: 23127127
[TBL] [Abstract][Full Text] [Related]
22. [International Conference on Immunotherapy of Cancer. New York, 5.-7.XI.1975].
Bendixen G
Ugeskr Laeger; 1976 Apr; 138(17):1036-7. PubMed ID: 4910
[No Abstract] [Full Text] [Related]
23. Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting report.
Pinto C; Bergmann M; Briukhovetska D; Nuessler V; Sznol M; von Bergwelt-Baildon M; Kobold S
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32114499
[TBL] [Abstract][Full Text] [Related]
24. Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005.
Britten CM; Gouttefangeas C; Kreiter S
Cancer Immunol Immunother; 2006 Apr; 55(4):475-80. PubMed ID: 16193336
[TBL] [Abstract][Full Text] [Related]
25. Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2-4, 2016.
Gallardo-Rincón D; Marquez JP; Celis E
Cancer Immunol Immunother; 2017 Sep; 66(9):1243-1247. PubMed ID: 28484800
[TBL] [Abstract][Full Text] [Related]
26. Ninth annual meeting of the Association for Cancer Immunotherapy (CIMT 2011), May 25-27, 2011, Mainz, Germany.
Hobohm K; Seppmann T; Britten CM; Hoff H
Cancer Immunol Immunother; 2012 Jan; 61(1):137-43. PubMed ID: 22048716
[No Abstract] [Full Text] [Related]
27. Report on the 2018 Cancer, Autoimmunity, and Immunology Conference.
Curran CS; Sommers CL; Young HA; Bourcier K; Mancini M; Sharon E
J Immunol; 2019 May; 202(10):2823-2828. PubMed ID: 30988117
[TBL] [Abstract][Full Text] [Related]
28. Tumor immunology: basic and clinical advances.
Beatty PL; Cascio S; Lutz E
Cancer Res; 2011 Jul; 71(13):4338-43. PubMed ID: 21712409
[TBL] [Abstract][Full Text] [Related]
29. CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
Kranz LM; Beck JD; Grunwitz C; Hotz C; Vormehr M; Diken M
Hum Vaccin Immunother; 2017 Oct; 13(10):2272-2279. PubMed ID: 28846471
[No Abstract] [Full Text] [Related]
30. International Society for Cell and Gene Therapy of Cancer 2009 Annual Meeting held in Cork, Ireland.
Guinn B; Casey G; Möller MG; Kasahara N; O'Sullivan GC; Peng KW; Tangney M
Hum Gene Ther; 2010 Jan; 21(1):9-26. PubMed ID: 20017714
[TBL] [Abstract][Full Text] [Related]
31. CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy.
Berger PA; Freitag J; Linkenbach SC; Merz L; Schork M; Thevissen S; Yildiz I; Beck JD
Hum Vaccin Immunother; 2022 Nov; 18(6):2124785. PubMed ID: 36222759
[TBL] [Abstract][Full Text] [Related]
32. The Cancer Research Institute 2013 Annual Symposium: Dynamics of host-tumor interaction.
Tontonoz M; Gee CE
Cancer Immunol Res; 2014 Feb; 2(2):105-11. PubMed ID: 24778274
[TBL] [Abstract][Full Text] [Related]
33. Cancer vaccines: looking to the future. Interview by Jenaid Rees.
Apostolopoulos V
Expert Rev Vaccines; 2013 Oct; 12(10):1125-6. PubMed ID: 24093953
[TBL] [Abstract][Full Text] [Related]
34. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
Madden DL
Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
[TBL] [Abstract][Full Text] [Related]
35. Cancer Vaccines - SMi's Fourth Annual Conference (September 16-17, 2015 - London, UK).
Searle B
Drugs Today (Barc); 2015 Sep; 51(9):569-73. PubMed ID: 26488036
[TBL] [Abstract][Full Text] [Related]
36. Immune based therapies in cancer.
Krüger C; Greten TF; Korangy F
Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in cancer immunology and immunology-based anticancer therapies.
Kumar S; Saini RV; Mahindroo N
Biomed Pharmacother; 2017 Dec; 96():1491-1500. PubMed ID: 29198747
[TBL] [Abstract][Full Text] [Related]
38. Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.
Brehm C; Huenecke S; Pfirrmann V; Rossig C; Mackall CL; Bollard CM; Gottschalk S; Schlegel PG; Klingebiel T; Bader P
Pediatr Hematol Oncol; 2013 Aug; 30(5):349-66. PubMed ID: 23758210
[TBL] [Abstract][Full Text] [Related]
39. Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): moving forward.
Malyguine A; Umansky V; Kotlan B; Aptsiauri N; Shurin MR
J Immunotoxicol; 2012; 9(3):231-5. PubMed ID: 22639903
[TBL] [Abstract][Full Text] [Related]
40. De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute.
Mellman I; Hubbard-Lucey VM; Tontonoz MJ; Kalos MD; Chen DS; Allison JP; Drake CG; Levitsky H; Lonberg N; van der Burg SH; Fearon DT; Wherry EJ; Lowy I; Vonderheide RH; Hwu P
Cancer Immunol Res; 2016 Apr; 4(4):279-88. PubMed ID: 27036972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
